Should I buy or sell Indivior stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Indivior in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" INDV shares. View INDV analyst ratings or view top-rated stocks .

What is Indivior's stock price target for 2024?

1 analysts have issued 1-year price targets for Indivior's stock. Their INDV share price targets range from $35.00 to $35.00. On average, they anticipate the company's stock price to reach $35.00 in the next twelve months. This suggests a possible upside of 132.6% from the stock's current price. View analysts price targets for INDV or view top-rated stocks among Wall Street analysts .

How have INDV shares performed in 2023?

Indivior's stock was trading at $22.68 at the beginning of the year. Since then, INDV stock has decreased by 33.6% and is now trading at $15.05. View the best growth stocks for 2023 here .

When is Indivior's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 15th 2024. View our INDV earnings forecast .

How were Indivior's earnings last quarter?

Indivior PLC (NASDAQ:INDV) issued its earnings results on Thursday, November, 9th. The company reported $0.34 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.30 by $0.04. The company earned $271 million during the quarter, compared to the consensus estimate of $265 million. Indivior had a positive trailing twelve-month return on equity of 370.37% and a negative net margin of 22.57%.

Who are Indivior's major shareholders?

Indivior's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Scopia Capital Management LP (6.03%), FMR LLC (3.99%), Artemis Investment Management LLP (2.27%), Polar Capital Holdings Plc (1.90%), Acadian Asset Management LLC (1.65%) and Liontrust Investment Partners LLP (1.45%).

How do I buy shares of Indivior?

Shares of INDV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Indivior Stock Price, News & Analysis (NASDAQ:INDV)

$15.05

-0.94 (-5.88%)

(As of 12/6/2023 ET)

Compare

Today's Range: $14.60
▼
$15.49
50-Day Range: $15.05
▼
$23.07
52-Week Range: $14.60
▼
$26.50

Volume: 63,039 shs
Average Volume: 11,271 shs
Market Capitalization: $2.08 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $35.00

Indivior MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 132.6% Upside
$35.00 Price Target
Short Interest: N/A
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 1.12
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 31.65%
From $1.39 to $1.83 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.28 out of 5 stars

Medical Sector

278th out of 957 stocks

Pharmaceutical Preparations Industry

90th out of 399 stocks

3.5

Analyst's Opinion

Consensus Rating
Indivior has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $35.00, Indivior has a forecasted upside of 132.6% from its current price of $15.05.
Amount of Analyst Coverage
Indivior has received no research coverage in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for INDV.

0.0

Dividend Strength

Dividend Yield
Indivior does not currently pay a dividend.
Dividend Growth
Indivior does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for INDV.

4.0

News and Social Media Coverage

News Sentiment
Indivior has a news sentiment score of 1.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.50 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for Indivior this week, compared to 1 article on an average week.
Search Interest
1 people have searched for INDV on MarketBeat in the last 30 days.
MarketBeat Follows
1 people have added Indivior to their MarketBeat watchlist in the last 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Indivior insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 36.26% of the stock of Indivior is held by institutions.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Indivior are expected to grow by 31.65% in the coming year, from $1.39 to $1.83 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Indivior is -8.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Indivior is -8.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Indivior has a P/B Ratio of 40.68. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Indivior Stock (NASDAQ:INDV)

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet. The company operates in approximately 40 countries worldwide. It has collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

INDV Stock Price History

30 days | 90 days | 365 days | Advanced Chart

INDV Stock News Headlines

December 5, 2023 | msn.com

London court throws out Suboxone representative lawsuit

November 20, 2023 | msn.com

Reckitt Benckiser, Indivior, ask London court to throw out Suboxone lawsuit

December 7, 2023 | Wealthpress (Ad)

Trading Experts Call It “The Perfect Tesla Trade”

Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.

November 17, 2023 | markets.businessinsider.com

Indivior Announces Share Repurchase Program - Quick Facts

November 16, 2023 | uk.finance.yahoo.com

Indivior PLC (2IVB.MU)

November 13, 2023 | finance.yahoo.com

Indivior PLC (INDV) Loses -17.71% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

November 10, 2023 | seekingalpha.com

Indivior PLC 2023 Q3 - Results - Earnings Call Presentation

November 3, 2023 | bizjournals.com

Global pharma to invest $60M, add jobs at Raleigh manufacturing site

December 7, 2023 | Wealthpress (Ad)

Trading Experts Call It “The Perfect Tesla Trade”

October 31, 2023 | morningstar.com

Indivior PLC Ordinary Share INDV

October 24, 2023 | marketwatch.com

Indivior to Pay $385 Mln in Settlement to Direct Purchasers for Suboxone Claims

October 23, 2023 | usatoday.com

A new 'fentanyl fighter' hits a market crowded with overdose reversal drugs

October 23, 2023 | msn.com

What's Going On With Pharma Company Indivior's Shares Today?

October 13, 2023 | benzinga.com

Publicly-Traded Addiction Treatment Co. Signs Exclusive Licensing Agreement With Alar Pharmaceuticals

October 11, 2023 | finance.yahoo.com

Indivior Enters an Exclusive Licensing Agreement with Alar Pharmaceuticals

August 29, 2023 | finance.yahoo.com

Indivior PLC (INDV) is on the Move, Here's Why the Trend Could be Sustainable

August 21, 2023 | nasdaq.com

Indivior To Pay $30 Mln To Resolve In Re Suboxone Antitrust MDL

August 21, 2023 | finance.yahoo.com

Indivior Reaches Agreement with End Payor Class to Resolve Their Antitrust Multi-District Litigation Claims

July 28, 2023 | benzinga.com

Indivior Stock (NASDAQ:INDV), Earnings Estimates, EPS, and Revenue

July 28, 2023 | seekingalpha.com

Indivior PLC 2023 Q2 - Results - Earnings Call Presentation

July 27, 2023 | finance.yahoo.com

Indivior Announces Q2/H1 2023 Financial Results

See More Headlines

Receive INDV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Indivior and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/09/2023
Today: 12/06/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 2/15/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:INDV
CUSIP: N/A
CIK: 1625297
Web: www.indivior.com
Phone: 804-379-1090
Fax: 804-379-1215
Employees: 1,000
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $35.00
High Stock Price Target: $35.00
Low Stock Price Target: $35.00
Potential Upside/Downside: +132.6%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.74)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 10.83
P/E Growth: N/A
Net Income: $-53,000,000.00
Net Margins: -22.57%
Pretax Margin: -30.35%
Return on Equity: 370.37%
Return on Assets: 11.26%

Debt

Debt-to-Equity Ratio: 2.02
Current Ratio: 0.98
Quick Ratio: 0.87

Sales & Book Value

Annual Sales: $1.04 billion
Price / Sales: 1.99
Cash Flow: $1.25 per share
Price / Cash Flow: 12.06
Book Value: $0.37 per share
Price / Book: 40.68

Miscellaneous

Outstanding Shares: 137,879,000
Free Float: N/A
Market Cap: $2.08 billion
Optionable: Not Optionable
Beta: 0.38

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. Mark Crossley
CEO & Executive Director
Mr. Ryan Preblick
CFO & Executive Director
Dr. Christian Heidbreder
Chief Scientific Officer
Mr. Jason Thompson
Vice President of Investor Relations
Ms. Cynthia Cetani
Chief Integrity & Compliance Officer
Mr. Jeffrey W. Burris (Age 51)
Chief Legal Officer
Mr. Jon Fogle
Chief Human Resources Officer
Mr. Richard Simkin
Chief Commercial Officer
Mr. Hillel West
Chief Manufacturing & Supply Officer
Ms. Nina DeLorenzo
Chief Global Impact Officer

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

INDV Stock Analysis - Frequently Asked Questions

Should I buy or sell Indivior stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Indivior in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" INDV shares.
View INDV analyst ratings or view top-rated stocks.
What is Indivior's stock price target for 2024?: 1 analysts have issued 1-year price targets for Indivior's stock. Their INDV share price targets range from $35.00 to $35.00. On average, they anticipate the company's stock price to reach $35.00 in the next twelve months. This suggests a possible upside of 132.6% from the stock's current price.
View analysts price targets for INDV or view top-rated stocks among Wall Street analysts.
How have INDV shares performed in 2023?: Indivior's stock was trading at $22.68 at the beginning of the year. Since then, INDV stock has decreased by 33.6% and is now trading at $15.05.
View the best growth stocks for 2023 here.
When is Indivior's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, February 15th 2024.
View our INDV earnings forecast.

How were Indivior's earnings last quarter?: Indivior PLC (NASDAQ:INDV) issued its earnings results on Thursday, November, 9th. The company reported $0.34 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.30 by $0.04. The company earned $271 million during the quarter, compared to the consensus estimate of $265 million. Indivior had a positive trailing twelve-month return on equity of 370.37% and a negative net margin of 22.57%.
Who are Indivior's major shareholders?: Indivior's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Scopia Capital Management LP (6.03%), FMR LLC (3.99%), Artemis Investment Management LLP (2.27%), Polar Capital Holdings Plc (1.90%), Acadian Asset Management LLC (1.65%) and Liontrust Investment Partners LLP (1.45%).
How do I buy shares of Indivior?: Shares of INDV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:INDV) was last updated on 12/7/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Indivior Stock Price, News & Analysis (NASDAQ:INDV)

Indivior MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Indivior Stock (NASDAQ:INDV)

INDV Stock Price History

INDV Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

INDV Stock Analysis - Frequently Asked Questions

Overall MarketRank^™